Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Alt a 1Equus caballusHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.1 - Asymptomatic2014SpainIgE502.00020140625, Armentia A
1.11 - Esophagitis, Diagnosed2014SpainIgE6711.90020140625, Armentia A
1.9 - Pollen Allergy2014SpainIgE504.00020140625, Armentia A
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE769.20020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3511.43020130605, Simon D
1.4 - Respiratory Symptoms, Diagnosed2013SpainIgE18719.80020131016, Feliu A
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14015.71020130111, Ott H
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE966.25020120528, Patelis A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2012AustriaIgE5498.15020120310, Twaroch TE
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9917.17020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2012ItalyIgE2696.15020120310, Twaroch TE
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012SpainIgE4297.60020120529, Morin M
6.2 - General Population (Adults)2012SwedenBPT3711.08020120528, Patelis A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8624.41020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164089.56020100301, Scala E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainIgE2195.23020101125, Fernandez C
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2090.00020091005, Ott H
10.1 - Normal Control2009BelgiumBPT260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumBPT220.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2020.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE378.10020090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2005SpainIgE4297.60020050610, Asturias JA
5.3.1 - Source Exposed (Symptoms, IgE)2003United StatesIgE5780.7002003, Kurup VP
5.3.1 - Source Exposed (Symptoms, IgE)2001United StatesIgE5875.9002001a, Vailes LD
5.3.1 - Source Exposed (Symptoms, IgE)2001United StatesIgE1952.6002001a, Vailes LD
3.2.1 - Source Sensitized (IgE)1996CanadaIgE (IB)5780.7001996, De Vouge MW
Developed by
Panservice